More reads
- AskBio’s $235 million financing provides clues to the direction of gene therapy investment. (STAT Plus)
- Intercept tries to outrun pharma in race for the next blockbuster. (Bloomberg)
- Evofem Biosciences raises $80m for new hormone-free contraceptive. (Financial Times)
- Scientists still don’t know what gives ketamine its antidepressant effect. Stressed mice might offer a clue. (STAT)
.png)
No hay comentarios:
Publicar un comentario